Where Tech Meets Bio
Latest News
Research Grid has secured $6.48 million in seed funding, led by Fuel Ventures, with additional support from Arve Capital, Ada Ventures, and Morgan Stanley Inclusive …
Read More
UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report
New research from the British Business Bank reveals that life sciences venture capital (VC) funds are delivering higher realized returns for investors compared to the …
Read More
New AI-Enhanced Architecture for EHDS2 Implementation Released
BC Platforms, Modirum Platforms, VEIL.AI, and Productivity Leap have jointly developed a reference architecture to implement the European Health Data Space secondary (EHDS2) framework, enabling …
Read More
Latest News
BC Platforms Unveils Platform to Unify EU Healthcare Data Governance
UK Government and Oxford Nanopore to Launch Pandemic Early Warning System
Elsevier Supports Pistoia Alliance to Tackle AI Challenges in Drug Discovery
Accenture Invests in 1910 Genetics to Enhance Drug Discovery With AI
Evogene Partners with Google Cloud to Build AI Model for Small Molecule Discovery
Absci and Twist Bioscience Collaborate to Design a Novel Antibody with Generative AI
Latest Insights
by Rupert Colbourne
How Enterprise Architecture is Powering Digital Transformation in Healthcare
The healthcare industry is confronting critical challenges including a systemic labour shortage, rising costs (estimated to grow to its highest level in 13 years) and …
Read More
by Andrii Buvailo
12 Useful Mobile Apps For Life Scientists
(Updated: 2.09.2024) Nowadays mobile devices are ubiquitous with an estimated number of smartphones and tablet PCs to exceed two billion globally. The availability of internet …
Read More
Cautious Optimism in 2024 for Healthcare M&A
by Merlin Piscitelli
AI Is Key to Democratizing Drug Discovery
by Andrey Doronichev
Key Trends in Aging Research: Where Are We Now?
by Andrii Buvailo, PhD
Global Pharma R&D Investments Surpass $276 Billion Annually, Exceeding Previous Estimates
by Roman Kasianov
The Promise of Chatbots in Clinical Trials
by Illia Petrov
Even 10 Minutes Matter in Cancer Research
by Andrii Buvailo, PhD
How Enterprise Architecture is Powering Digital Transformation in Healthcare
by Rupert Colbourne
UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas
by Roman Kasianov
From Our Partners
Sponsored by
Lantern Pharma
AI Breaches the Barrier Towards Better CNS Drug Discovery
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
MEDSIR
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Partner Events
London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
Future Labs, Automation and Technology Summit West
Event Date: Nov. 12, 2024 - Nov. 12, 2024
Location: United States of America (San Diego, California)
Website: Link
Promo Code: BIOPHARMA15
Read more ›››
BIOCHINA 2025
Event Date: March 13, 2025 - March 15, 2025
Location: China (Suzhou International Expo Center)
Website: Link
Promo Code: biopharmatrend (valid till 2024-10-31)
Read more ›››
Case Studies
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Interviews
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
U.S. Frontiers in Biotech: Interview with Abigail Kukura about Strategy, Science, and the Road Ahead
The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández
[Interview] This Vancouver-based Startup Plans To Boost Drug Design With AI
Most Read
14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)
5 AI-Powered Companies Transforming the Future of Fertility Care
The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing
7 Promising RNA Biotech Companies To Watch in 2024